Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

AHA.18: Sacubitril-valsartan combo shows promise for acute decompensated HF

Sacubitril-valsartan therapy was associated with greater reductions in N-terminal pro-B-type natriuretic peptide (NT-proBNP) than enalapril among patients hospitalized with acute decompensated heart failure, according to research presented Nov. 11 at the American Heart Association’s Scientific Sessions and published online simultaneously in the New England Journal of Medicine.

Thumbnail

AHA.18: VITAL, REDUCE-IT deliver mixed results for fish oil products

VITAL and REDUCE-IT—both highly anticipated trials revolving around the cardiovascular benefits of fish oil products—delivered mixed results at this year’s AHA Scientific Sessions in Chicago, with one trial observing few heart benefits from omega-3s while the other saw a 25 percent reduction in major cardiovascular events with a purified eicosapentaenoic acid product.

Thumbnail

AHA.18: Nonstatin therapies, CAC testing claim larger role in cholesterol guidelines

New cholesterol guidelines from the American Heart Association and the American College of Cardiology recommend adding ezetimibe and/or PCSK9 inhibitors to statin therapy for select high-risk patients, and also propose using coronary artery calcium (CAC) scoring as “a tiebreaker” to guide statin decisions for those at intermediate risk of atherosclerotic cardiovascular disease.

Thumbnail

How Snapchat saved a stroke patient’s life with 12 minutes to spare

Social media app Snapchat has been credited with saving 39-year-old Darnisha Ladd’s life after a recorded video helped physicians diagnose the young stroke survivor, allowing them to administer life-saving medication with 12 minutes to spare, the Omaha World-Herald has reported.

Thumbnail

Blue light shows promise for reducing blood pressure

Exposure to blue light could decrease an individual’s systolic blood pressure by as much as 8 mm Hg in just half an hour, researchers report in a study co-led by the University of Surrey, Heinrich Heine University Düsseldorf and Philips.

Just 5% of T1D patients in UK have insured access to flash glucose monitors

Up to a quarter of type 1 diabetes patients in England should have access to the Freestyle Libre, a flash glucose monitor that allows diabetics to check their blood sugar without the need for finger pricks. But a recent investigation by the BMJ has concluded that, in reality, just 3 to 5 percent of eligible patients have access to the potentially life-changing technology.

Thumbnail

Teens face up to 7 times higher odds of AMI with cocaine, cannabis use

Cocaine, amphetamines and cannabis could raise adolescents’ risk for acute myocardial infarction (AMI), in some cases increasing a teen’s odds for MI by up to seven times, according to research out of Shanghai Jiao Tong University School of Medicine in China.

Thumbnail

Large nighttime meals tied to hypertension, prediabetes

It’s not just what people eat—but when—that may influence their risk of developing prediabetes and high blood pressure, according to preliminary research scheduled to be presented Nov. 10 at the American Heart Association’s Scientific Sessions in Chicago.